Bangladesh Medical University
Clinical trials sponsored by Bangladesh Medical University, explained in plain language.
-
New drug may offer safer option for Hormone-Driven high blood pressure
Disease control Recruiting nowThis study tests whether a newer drug, finerenone, works better and is safer than the standard drug spironolactone for people with high blood pressure due to primary aldosteronism—a condition where the adrenal glands make too much of the hormone aldosterone. About 104 adults with…
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Liver cancer trial tests combo therapy against single drug
Disease control Recruiting nowThis study tests whether adding a targeted chemotherapy procedure (TACE) to the drug lenvatinib works better than lenvatinib alone for people with liver cancer that cannot be removed by surgery. About 40 adults with early to advanced liver cancer will be enrolled. The goal is to …
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tests nerve blocks to ease severe cancer pain
Symptom relief Recruiting nowThis study compares two types of nerve blocks—coeliac plexus block and splanchnic nerve block—to see which one reduces pain better in adults with upper abdominal cancer. Forty-four participants will receive one of the procedures and be monitored for pain, opioid use, and quality …
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New pain block may cut opioid use after kidney surgery
Symptom relief Recruiting nowThis study tests whether a special nerve block, called an erector spinae plane block, can reduce pain and the need for strong painkillers after kidney removal surgery. About 66 adults having open nephrectomy will be randomly assigned to get either standard pain relief or the nerv…
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New painkiller mirogabalin takes on diabetic nerve pain
Symptom relief Recruiting nowThis study tests whether mirogabalin can reduce nerve pain in people with diabetes. 78 adults will take either mirogabalin or the standard drug pregabalin daily for 8 weeks. Researchers will measure pain levels, side effects, and quality of life to see if mirogabalin is a better …
Phase: PHASE4 • Sponsor: Bangladesh Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Digestive health mystery: study seeks to uncover hidden burden of stomach pain in rural bangladesh
Knowledge-focused Recruiting nowThis study aims to find out how many adults in rural Bangladesh have functional dyspepsia—a condition causing stomach pain or discomfort without any visible damage in the digestive tract. Researchers will interview 730 adults using a standard questionnaire and perform an upper en…
Sponsor: Bangladesh Medical University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC